Olema Pharmaceuticals Statistics

Total Valuation

OLMA has a market cap or net worth of $581.51 million. The enterprise value is $322.12 million.

Market Cap	581.51M
Enterprise Value	322.12M

Important Dates

The next estimated earnings date is Tuesday, May 14, 2024, after market close.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

OLMA has 55.91 million shares outstanding. The number of shares has increased by 13.13% in one year.

Shares Outstanding	55.91M
Shares Change (YoY)	+13.13%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	3.94%
Owned by Institutions (%)	96.23%
Float	28.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.29
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.33, with a Debt / Equity ratio of 0.01.

Current Ratio	12.33
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.70% and return on invested capital (ROIC) is -40.95%.

Return on Equity (ROE)	-44.70%
Return on Assets (ROA)	-41.00%
Return on Capital (ROIC)	-40.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.31M
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +91.53% in the last 52 weeks. The beta is 2.11, so OLMA's price volatility has been higher than the market average.

Beta (1Y)	2.11
52-Week Price Change	+91.53%
50-Day Moving Average	11.66
200-Day Moving Average	12.16
Relative Strength Index (RSI)	45.08
Average Volume (30 Days)	793,913

Short Selling Information

The latest short interest is 8.97 million, so 16.05% of the outstanding shares have been sold short.

Short Interest	8.97M
Short Previous Month	8.10M
Short % of Shares Out	16.05%
Short % of Float	31.51%
Short Ratio (days to cover)	8.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-104.96M
Pretax Income	-96.66M
Net Income	-96.66M
EBITDA	-94.98M
EBIT	-96.66M
Earnings Per Share (EPS)	-$2.14

Full Income Statement

Balance Sheet

The company has $261.81 million in cash and $2.42 million in debt, giving a net cash position of $259.39 million or $4.64 per share.

Cash & Cash Equivalents	261.81M
Total Debt	2.42M
Net Cash	259.39M
Net Cash Per Share	$4.64
Equity / Book Value	253.90M
Book Value Per Share	4.54
Working Capital	244.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$83.73 million and capital expenditures $14,000, giving a free cash flow of -$83.71 million.

Operating Cash Flow	-83.73M
Capital Expenditures	14,000
Free Cash Flow	-83.71M
FCF Per Share	-$1.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OLMA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.13%
Shareholder Yield	-13.13%
Earnings Yield	-16.62%
FCF Yield	-14.40%

Analyst Forecast

The average price target for OLMA is $21.80, which is 109.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.80
Price Target Difference	109.62%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2